Job Description:

The Vice President, Human Resources, Diagnostics serves as the senior HR leader and strategic business partner to the President and Leadership Team, responsible for aligning people strategy with business objectives to drive growth, innovation, organizational effectiveness, and operational excellence across a global organization. Reporting directly to the President, DEXIS, with a dotted-line relationship to the Envista Chief Human Resources Officer, this executive operates at the intersection of business strategy and enterprise talent leadership, ensuring alignment between business priorities and enterprise HR initiatives.

As a member of both the DEXIS Leadership Team and the broader Envista HR Leadership Team, the VP HR advises on talent, leadership, culture, organizational design, workforce planning, and change management, helping build the organizational capabilities needed to achieve strategic objectives. This role serves as a trusted advisor to senior leaders while influencing both business and enterprise decisions within a global, matrixed environment.

The successful candidate will play a key role in driving organizational transformation, strengthening leadership capability, advancing talent strategies, and fostering a high-performance culture across commercial, manufacturing, R&D, quality, regulatory, and corporate functions. This leader will bring a proven track record of partnering with executives, leading complex change, and translating business strategy into impactful people initiatives that support growth, innovation, and business performance.

Key Responsibilities

Partner closely with the President and executive leadership team to shape and execute business strategies through effective talent, organizational, and culture initiatives.
Serve as a trusted advisor and coach to senior leaders on organizational effectiveness, leadership capability, succession planning, workforce strategy, team performance, and change leadership.
Lead the development and execution of integrated talent strategies that attract, develop, engage, and retain top talent while building a sustainable leadership pipeline for current and future business needs.
Drive enterprise talent management processes, including succession planning, leadership assessment, executive coaching, performance management, high-potential development, and leadership effectiveness initiatives.
Lead organizational design and workforce planning efforts to ensure optimal structures, capabilities, and resource alignment that support growth, scalability, agility, and business performance.
Champion a culture of accountability, inclusion, engagement, innovation, and continuous improvement while promoting company values and fostering an exceptional employee experience.
Partner with business leaders to drive organizational transformation, restructuring, integration, and change management initiatives resulting from strategic growth priorities, acquisitions, or evolving business needs.
Utilize people analytics, workforce insights, and organizational metrics to identify opportunities, inform decision-making, and improve business outcomes.
Provide strategic oversight of employee relations, ensuring effective resolution of complex issues while balancing employee experience, business needs, and legal compliance.
Collaborate with Corporate HR Centers of Excellence to implement enterprise talent, compensation, leadership development, total rewards, DE&I, and employee engagement strategies within the business.
Lead, develop, and inspire a high-performing HR team, building organizational capability and ensuring consistent delivery of HR programs and services across all regions.
Ensure compliance with employment laws, regulations, company policies, and ethical business practices across global operations while effectively managing risk.
Foster strong partnerships across functions and regions to drive alignment, enhance collaboration, and accelerate execution of business and talent priorities.
Act as a catalyst for business performance by ensuring the organization has the leadership, culture, talent, and organizational capabilities required to achieve short- and long-term strategic objectives.

Job Requirements:

Required Education

Bachelor's degree in Human Resources, Business Administration, Organizational Development, Psychology, or a related field
Master's degree (MBA, Human Resources, Organizational Development, or related discipline) preferred
15+ years of progressive Human Resources leadership experience, including significant experience supporting large, complex, global organizations
Demonstrated success serving as a strategic business partner to senior executives and leadership teams
Proven experience leading organizational transformation, large-scale change initiatives, restructuring efforts, or business integrations
Deep expertise in talent management, leadership development, succession planning, organizational design, workforce planning, and employee engagement
Experience operating effectively within global, matrixed organizations and influencing stakeholders across multiple levels and functions
Track record of building high-performing teams and developing organizational capability
Strong business acumen with the ability to connect people strategies directly to business outcomes and financial performance

Preferred Experience

Experience within medical devices, diagnostics, digital health, life sciences, biotechnology, healthcare technology, pharmaceuticals, or other highly regulated industries
Experience supporting global commercial organizations and partnering with manufacturing, supply chain, quality, regulatory, R&D, and corporate functions.
Global HR leadership experience supporting international teams and business operations
Experience supporting mergers& acquisitions, integrations, and large-scale transformation initiatives
Experience operating within a publicly traded, multinational organization

Target Market Salary Range:

Actual compensation packages take into account a wide range of factors that are unique to each candidate, including but not limited to geographic location; skill sets; relevant education and certifications; depth of experience; performance; and other business and organizational needs. The disclosed reasonable estimate has not been adjusted for the applicable geographic differential associated with the location at which the position may be filled. At Envista, it is not typical for an individual to be hired at or near the top of the range for their role and compensation decisions are dependent on the facts and circumstances of each case. The total compensation package for this position may also include an annual performance bonus, medical/dental/vision benefits, 401K match, and/or other applicable compensation plans.

$227,800 - $278,400

Operating Company:

DEXIS

Envista and all Envista Companies are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law. The “EEO is the Law” poster is available at: http://www.dol.gov/ofccp/regs/ compliance/posters/pdf/eeopost.pdf.

Envista and its family of companies (Envista) will not accept unsolicited resumes from any source other than directly from a candidate. Envista will consider unsolicited referrals and/or resumes submitted by vendors such as search firms, staffing agencies, professional recruiters, fee-based referral services and recruiting agencies (Agency) to have been referred by the Agency free of charge and Envista will not pay a fee for any placement resulting from the receipt such unsolicited resumes. An Agency must obtain advance written approval from Envista's internal Talent Acquisition or Human Resources team to submit resumes, and then only in conjunction with a valid fully-executed contract approved by the Global Talent Acquisition leader and in response to a specific job opening. Envista will not pay a fee to any Agency that does not have such agreement and written approval in place.

About the company

Envista provides a comprehensive range of dental products, including implants, orthodontic braces, clear aligners, and digital imaging equipment. These products work together to support nearly 90% of a dentist's clinical needs, from initial digital diagnosis and treatment planning to the physical tools used for surgery and infection prevention. Unlike many competitors that focus on a single niche, Envista offers a massive portfolio of established brands like Nobel Biocare and Ormco that cover both specialized surgery and everyday consumables. The company's goal is to provide dental professionals with a complete, integrated ecosystem of tools and software to improve patient outcomes globally.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Brea, California

Founded

2004

Get referred to Envista

See people who can refer or advise you

Simplify's Take

What believers are saying

Envista raised 2026 guidance on August 5, 2026, after Q2 revenue reached $730.5 million.
Kerr launched in India on September 1, 2026, expanding access beyond metro dental chains.
Investor Day on September 17, 2026 should showcase new products and quantified margin leverage.

What critics are saying

China VBP hits orthodontics and implants in 2026, pressuring pricing and mix immediately.
Q4 2026 billing-day headwind and second-half slowdown expose fragile organic momentum.
Restructuring charges and facility realignments signal ongoing cost pressure if growth disappoints in 2027.

What makes Envista unique

Envista spans implants, orthodontics, imaging, and consumables across 150 countries.
Nobel Biocare, Ormco, Kerr, and DEXIS create cross-sell leverage inside one dentist workflow.
The company owns recurring consumables plus hardware, reducing dependence on single-product cycles.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

1 year growth

14%

2 year growth

16%

Express-Press-Release.net

Oct 12th, 2026

Chairs, handpieces, and sterilizers: the unsung heroes of the dental equipment market.

Chairs, handpieces, and sterilizers: the unsung heroes of the dental equipment market. Dentistry is changing quickly. Clinics that relied on analog tools now run digital scanners, laser systems, and connected treatment units. This post covers how the dental equipment market is structured, what is pushing it forward and holding it back, and where it is headed through 2033. Core Market Framework Dental equipment covers the instruments and systems used to examine, manipulate, treat, and restore oral disorders. Grand View Research segments the dental equipment market by product and region. By product: * Dental radiology equipment: intraoral and extraoral imaging, including digital X-ray units and sensors * Dental lasers: diode, carbon dioxide, and YAG lasers * Systems & parts: instrument delivery systems, vacuums and compressors, CBCT systems, CAD/CAM, furnaces, and electrosurgical equipment * Laboratory machines: ceramic furnaces, hydraulic presses, electronic waxers, and similar tools * Hygiene maintenance devices: sterilizers, air purification systems, and needle incinerators * Other equipment: chairs, handpieces, light-cure units, and scaling units By region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with country-level coverage across more than 20 markets. The competitive landscape has two tiers. Established players such as Dentsply Sirona, Planmeca, A-dec, Straumann, Envista, and 3M compete on broad portfolios, large installed bases, and heavy R&D spending. Emerging players such as AMD Lasers, Zolar Technology, and GIGAAMEDICAL compete on price, niche products, and regional distribution, mostly targeting small and mid-sized clinics. Discover more Read Daily News Hire PR Firms Go Deeper. Need the data behind these numbers? Get a look at the report's market estimates, trend analysis, and forecasts. Download Free Sample Report Strategic Drivers & Impeding Mechanics What's driving growth * A rising burden of oral disease. Oral diseases affect an estimated 3.9 billion people worldwide, according to the FDI World Dental Federation. Untreated tooth decay is the most prevalent condition in the Global Burden of Disease Study. Diets high in sugar, tobacco and alcohol use, and poor hygiene keep caries and periodontal disease widespread. More patients need diagnosis and treatment, so clinics and hospitals need more chairs, imaging systems, scanners, sterilization units, and lasers. * An aging population. By 2050, about one in six people globally will be over 65, up from one in eleven in 2019. That is roughly 1.5 billion people, and older patients have a higher need for restorative and surgical dental care. * Digital dentistry. Intraoral scanners, CAD/CAM systems, 3D printers, digital radiography, and cloud-connected practice software are becoming standard. They support same-day restorations, cut manual errors, and improve diagnostic accuracy and the patient experience. * Policy, awareness, and medical tourism. Public oral health programs, preventive care campaigns, and expanding clinic networks all lift demand. Dental medical tourism adds to it, especially in Asia, where patients are drawn by shorter waits, lower costs, and skilled practitioners. What's holding it back The high cost of imaging equipment. CBCT scanners, panoramic X-ray systems, cephalometric units, and digital radiography systems require large upfront investment. Beyond the purchase price, practices also pay for installation, software licensing, maintenance, calibration, radiation safety compliance, and staff training. For small and independent practices, that total cost can delay adoption or push them toward cheaper alternatives. The pandemic also left a mark. Clinic closures, PPE shortages, and the need to invest in new safety protocols strained many practices, although the market recovered once clinics reopened. Discover more Scale Logistics Need it tailored to your business? Add countries or segments, align the report to your product definitions, or go deeper on competitors, with up to 20% free customization. Customize This Report Market Overview & Growth Trajectory The global dental equipment market was valued at USD 12.5 billion in 2025 and is estimated at USD 13.2 billion in 2026. It is projected to reach USD 20.9 billion by 2033, growing at a CAGR of 6.8% from 2026 to 2033. Products. Systems & parts led in 2025 with a 40.4% revenue share, since these are the core tools behind almost every procedure. Dental lasers are the fastest-growing segment, with a projected CAGR of 9.2%. They are increasingly used in surgery, gum reshaping, and teeth whitening, and they offer controlled blood loss and less need for sutures. Regions. North America held the leading position in 2025 with a 38.6% share and is expected to grow at a 7.0% CAGR. The U.S. anchors the region thanks to strong infrastructure, established reimbursement policies, and a concentration of key players. Asia Pacific is the fastest-growing region at a 7.5% CAGR, helped by supportive government policies, a rising geriatric population, growing procedure demand, and strong medical tourism in China, Japan, and India. What it means for stakeholders. Success will likely go to companies that offer integrated digital ecosystems rather than standalone devices. That means diagnostics, imaging, treatment, and software working together, backed by clinical support, strategic partnerships, and strong distribution. Expansion through partnerships and acquisitions in emerging regions is also a clear competitive pattern. Explore our dedicated business services: Prism AI: Market Intelligence with Cited Research- Ask questions in plain language and get insights drawn from Grand View Research's entire research library, with sources cited. Create your free account today. U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today Matched content.

Amritt Inc.

Sep 4th, 2026

California's Envista expands dental products business in India with Kerr launch.

California's Envista expands dental products business in India with Kerr launch. * September 4, 2026 India is one of the few large markets where primary dental care is still reaching new consumers; global companies that provide devices and consumables for Indian dentists have found a fertile market. Here in Southern California where I live, Brea-based Envista Holdings is expanding its presence in India with the launch of its Kerr dental consumables business, as the dental products company that owns Kerr, Ormco, and Nobel Biocare seeks to diversify its revenue base. The company announced on September 1 that Kerr products will now be introduced more broadly in India, with an initial focus on restorative and endodontic dentistry. Kerr, a longstanding dental brand within Envista's portfolio, produces materials and other consumables used by dentists in restorative procedures and root canal treatment. For Envista, the move reflects the increasing importance of India within its international growth strategy. The country has a large base of dental professionals, while demand for higher-quality restorative and aesthetic dentistry is increasing as incomes rise, private dental practices expand and patients become more aware of available treatments. India's dental market is also changing beyond the largest metropolitan areas. Private clinics, dental chains and specialty practices have expanded in many Tier 2 and Tier 3 cities, creating a broader potential market for international manufacturers of dental equipment, materials and consumables. Envista CEO Paul Keel described India as one of the company's strategic growth markets and pointed to the country's expanding dental infrastructure and changing clinical practices as reasons for further investment. The company plans to support the Kerr introduction with clinician training, hands-on workshops and continuing education programs. It also expects to work with universities, professional organizations and other industry participants. A multi-city program involving international dental experts is planned following the initial launch. This approach is significant because selling medical and dental products in India often involves more than establishing distribution. Manufacturers frequently need to invest in clinician education, technical support and relationships with hospitals, universities and professional organizations, particularly when introducing products that compete on clinical performance rather than primarily on price. Envista also intends to expand Kerr's reach beyond India's largest cities. Vikrant Trilokekar, managing director of Envista India and South Asia, said the company plans to combine new product introductions with local service and technical support. Kerr itself is not a new brand. Founded 135 years ago, it has an established international presence in restorative and endodontic dentistry. Bringing a broader Kerr portfolio into India therefore represents less of a new-market experiment than an extension of Envista's existing global product strategy into a market it sees as increasingly important. What that means for medical device companies For American healthcare companies, Envista's move is another example of how India is evolving from a market served primarily through limited product distribution into one where multinational companies are investing more deliberately in local market development. As India's healthcare infrastructure expands beyond its largest cities, companies that can combine international products with local training, service and clinical engagement may find a substantially larger addressable market than was available a decade ago. About amritt. Who we are. Amritt Inc. is a management advisory service facilitating trade between the world and India. Amritt was founded in 2003 and since then it has provided guidance to western companies in entering new markets, global strategy execution, finding and managing supplier partners, and establishing overseas offices. Our primary focus is in helping American, Canadian and European executives to attain success in India.

Radical Compliance

Sep 4th, 2026

Compliance Jobs Report: sept. 4.

Compliance Jobs Report: sept. 4. Another brisk Compliance Jobs Report as Radical Compliance head into the Labor Day Weekend! Radical Compliance has new hires at Bristow Group, Ulta Beauty, Morgan Stanley, ABB, and elsewhere; and unfortunately some cutbacks at Uber and Entain. Lots of promotions too, and job leads in market research, higher education, and pharmaceuticals. Radical Compliance gather the Jobs Report news items from LinkedIn, press releases, and wherever else Radical Compliance can find tips - and thank you to everyone who sends them in, you make the Jobs Report possible! If you have any gossip to share (even confidentially) email me at [email protected] or find me on LinkedIn. Compliance Jobs. This week Radical Compliance begin with the Bristow Group, which provides helicopter and other aviation services to the oil & gas industry; it just hired Daniel Elustondo as chief compliance officer. Elustondo joins the Houston-based company after seven years at Shell, where he had been senior legal counsel in the regulatory group. Next is an update on Melissa Clawson, who announced last week that she was stepping down as chief audit executive at restaurant chain Wendy's. Clawson has glammed up with a new gig at Ulta Beauty, where she will be chief audit executive. Envista Holdings Corp., a maker of dental equipment, has hired Matt Silverman as senior director of global trade compliance. Silverman was last seen at Caterpillar, where he was assistant general counsel of compliance until last year. Silverman also does a fair bit of writing and speaking about trade compliance, which probably keeps him quite busy these days. Rebekah Mihm has a new job as head of legal operations, ethics, and ESG at UFP Technologies, a maker of sterile packaging and other medical equipment. Mihm comes to UFP from Harman International, where she had been director of corporate sustainability and ESG until this past spring. Looks like a few folks have been exiting British betting business Entain lately. Karen Nightingale has stepped down as group director of ethics and compliance, a role she held at Entain since 2023. Anandee Chowdhury also separated from the company the other week after two years there; she had been a group ethics and compliance associate. (If anyone wants to leak any other news of Entain restructurings, you can always reach me at [email protected].) James Martinelli has turned up at Morgan Stanley, as an executive director on the Wall Street giant's financial crimes compliance team. Martinelli comes to Morgan Stanley from FinCEN, the U.S. anti-money laundering regulator, where he had been associate director of regulatory and strategic affairs. Aveanna Healthcare has hired Kristi Cuffe as a compliance manager, working from Tampa, Fla. Cuffe joins the Atlanta-based Aveanna after six years at Family First Homecare, most recently as a compliance specialist. Orba Capital, an asset management firm based in New York, has hired Colleen Kilfoyle as chief compliance officer. Kilfoyle comes to Orba after 11 years at Sculptor Capital Management, the last two of them as chief compliance officer. Sumanta Datta has left his job as global head of compliance for analytics firm Wood Mackenzie to join Petroleum Development Oman as a compliance executive. ABB has hired Angel Corbacho as lead investigator for the EMEA region. Corbacho previously worked at cybersecurity firm Cloudflare as senior counsel for legal compliance; he's based in Portugal. Wellspace Health has hired Daniel Goulart as compliance program specialist. Goulart comes to the California-based company after 10 years at Sutter Health, most recently as a privacy and information security consultant. Dana Cook just landed at Boeing Corp. as a senior manager in compliance risk management. Cook comes to Boeing after three years at McKinsey as a "manager of compliance capabilities," but Cook had worked at Boeing for nearly a decade before that in various compliance roles. M&T Bank in Buffalo, N.Y., has hired Victoria Komjathy as a senior specialist in AI governance. Komjathy joins the bank from Capital One, where she had been a senior risk manager since 2024. IBM subsidiary Confluent has hired Marina Kaganovich as global head of product regulatory compliance. Kaganovich comes to Confluent (a cloud services business) from Google, where she had worked in trust and compliance in the office of the CISO there. In Italy, Annette Amato has left Johnson & Johnson, where she had worked on assessment and consulting projects in healthcare compliance; to join orthopedics manufacturer DePuy Synthes as manager of compliance policies, training, and communication. Deepti Bhandari has joined Otis Elevator as director of ethics and compliance for the company's Asia-Pacific region. Bhandari comes to Otis from Abbott, where she had been head of the company's ethics and compliance office in Asia. Jennifer Scalise-Mullett has a new gig at Turbett Surgical, a small medical manufacturing business in upstate New York, as vice president of quality, regulatory, and compliance. Scalise-Mullett was last seen at Boston Pharmaceuticals as vice president of compliance until the end of 2025, when the company was acquired by GSK. Raytheon has hired Jen Zrilska as a compliance manager. Zrilska joins the defense contractor from Dow Jones, where she had been head of due diligence for the Americas region. Andrzej Bełza has been hired at Coloplast as a global trade and sanctions compliance manager, working from the company's offices in Poland. Bełza previously spent five years at Radiometer, where he had been a global trade compliance specialist. The Orix Group, a Japanese financial services conglomerate, has hired Junyeon Park as compliance counsel and global investigations lead. Park comes to Orix from the law firm Herbert Smith Freehills, where she had been counsel for several years. And incidentally, you may have seen news that Uber is cutting 3,000 jobs, or about 10 percent of its global workforce. I've noticed a small but steady stream of risk, compliance, and audit professionals at Uber subsequently announcing on LinkedIn that they've lost their jobs. If your organization is hiring or you can otherwise help out these folks, they're out there. Moving up the ladder. Mastercard has promoted Howard Fields from group head of AML, export control, and sanctions compliance to executive vice president of risk and compliance enterprise solutions. Tanya Rines has moved into a new role at Eli Lilly & Co., going from associate director of global ethics and compliance to associate director of trade sanctions compliance. Option Care Health in Chicago has promoted Ian O'Brien from senior director of compliance for business partners to vice president of the same. Cora Colvin has a new role within the Cencora corporate empire as chief compliance officer at Retina Consultants of America, recently acquired by Cencora. Previously Colvin had been a group compliance officer at Cencora. Brooke Nelson has a new role within Sanofi, as head of ethics and business integrity for global operations. Nelson had previously been vice president of ethics and business integrity for Sanofi's North America operations. She has also relocated from Boston to Paris! Ikea has promoted Michelle Ackerman from senior manager of third-party risk and compliance to operational risk management and compliance manager. The International Federation of Red Cross and Red Crescent Societies has promoted Tristan Lemelle from acting investigations manager to head of investigations. Construction equipment manufacturer CNH has promoted Sarochinee Klinhorm from Asia-Pacific regional head of compliance to regional head of compliance and data protection officer. Shepherd Insurance has promoted Kylie Fields from compliance manager to director of compliance. Brittany Foglia has moved up at U.S. Renal Care from divisional compliance officer to senior divisional compliance officer. And German logistics giant Kuehne+Nagel has promoted Alissa Carneiro from customs and authorizations expert to national customs compliance manager. Vendors & service providers. Joe Hill has left his job at Honeywell as general counsel for trade sanctions and AML compliance, to take up with FTI Consulting as a managing director (presumably advising on the same issues). Open req orders. Ionis Pharmaceuticals is looking for a vice president of compliance. Job is based in Carlsbad, Calif. (just outside San Diego) or can be remote for the right candidate. Salary range is listed at $280,000 to $350,000. Market research firm Circana has two early-career compliance roles open! First is a policy and training analyst job, salary range listed at $90,000 to $105,000. Second is a sustainability analyst job, salary range $85,000 to $100,000. Both jobs can be remote for the right candidate. Dartmouth College is seeking a chief compliance officer. Job is based in Hanover, N.H.; salary range not provided! #NotCool Compliance meme of the week. That's all for this week's report. As always, if you have a tip or want to brag about your new job, promotion, career milestone, or anything else, email me at [email protected] or find me on LinkedIn. I'm always happy to give credit to the many hard-working people here in its corner of the business universe. Posted in News

Webindia123

Sep 1st, 2026

Envista Announces the Launch of Kerr Consumables in India, Reinforcing Its Commitment to Advancing Oral Healthcare

Envista Announces the Launch of Kerr Consumables in India, Reinforcing Its Commitment to Advancing Oral Healthcare | NEWS HOME " BUSINESS Envista Announces the Launch of Kerr Consumables in India, Reinforcing Its Commitment to Advancing Oral Healthcare | / | COMMENT | | September 1, 2026 1:59:54 PM IST | BusinessWire India Mumbai (Maharashtra) [India], September 1: Envista, a global leader in dental products and technologies, today announced the launch of Kerr Consumables in India, highlighting the growing importance of India and its long-term commitment to advancing oral healthcare in the country. India's dental industry is entering a new phase of growth, driven by increasing oral health awareness, rising demand for restorative and aesthetic dentistry, rapid expansion of dental infrastructure and greater adoption of advanced clinical technologies. As clinicians increasingly prioritise evidence-based, high-quality solutions that deliver predictable outcomes, the market presents significant opportunities for innovation, education and long-term collaboration to elevate the standard of patient care. Highlighting the strategic importance of India to Envista's growth journey, Paul Keel, CEO, Envista, said, "India is one of Envista's strategic growth markets globally, and its growing dental infrastructure, evolving clinical practices and increasing demand for high-quality restorative care present significant opportunities for the future. The launch of Kerr is an important milestone in our commitment to India, where we are making significant investments to ensure our customers can provide better patient care." Elaborating on Kerr's focus on quality and its commitment to the dental community in India, Jay Issa, Senior Vice President, Envista Markets said, "Kerr has earned the trust of dental professionals worldwide through quality and clinical performance. As we establish our presence in India, we are focused on building lasting relationships through quality products, education, scientific collaboration and strong partnerships with universities, professional organizations and industry partners." The launch of Kerr in India comes during the brand's landmark 135th anniversary year, underscoring its long-standing legacy of quality, clinical excellence and innovation. With a focus on restorative and endodontic dentistry, Kerr will support Indian dental professionals and institutions through evidence-based solutions, hands on workshops, and continuing education. Its restorative and endodontic portfolio is backed by decades of clinical experience and continuous innovation. Speaking about Envista's approach to the Indian market and its vision for the dental community, Vikrant Trilokekar, Managing Director, Envista India and South Asia, said, "Our focus is on bringing the right new products and innovative solutions to Indian dental professionals, backed by exceptional local service and technical support. Through trusted brands, scientific education and partnerships, we aim to enhance customer experience and contribute to a stronger, more connected dental ecosystem." The company will also focus on strengthening its presence across key dental markets, including Tier 2 and Tier 3 cities, through greater clinician engagement and a multi -city roadshow with international experts following the launch. (ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same) | | LATEST COMMENTS | POST YOUR COMMENT | | Comments Not Available | | POST YOUR COMMENT | | / | TRENDING TOPICS | / | | Tariff, GST, Assembly, poll, election, T20, Trump, Iran, BRICS, sensex, Israel, Congress, BJP, CWG, Modi, FIFA, Pakistan, cricket, Budget | | CITY NEWS | | Delhi | Mumbai | Kolkata | | Chennai | Bangalore | Kochi | | MORE CITIES | | MORE BUSINESS NEWS | | SBI Life highlights the importance of ba... | | 'NATUREGRAM' will meet nutritional needs... | | Abhay Bhutada Foundation Supports Young... | | AIM Summit 2026 to Bring 50+ CMOs and 60... | | Envista Announces the Launch of Kerr Con... | | GIBS Business School, Bangalore Opens Ap... | | More... | | INDIA | WORLD | ASIA | | 'Growing threats to Constitution, people... | | ED raids residence of ex-Chhatisgarh CM... | | 'Water should have been released by June... | | 'Participate in this for every citizen's... | | Karnataka CM DK Shivakumar assures revie... | | 'Plan journeys in advance': Delhi Traffi... | | More... | | Top Stories | | Tension in Tarnaka as Telangana BJP... | | Expenzing unveils FinCat: A team of... | | Renukaswamy murder case: Actor Dars... | | "Cauvery water is Tamil Nadu's lega... | | One Indian among 12 killed in Russi... | | Tibetan community alleges "informat... | | Voter participation vs voter anonym... | | "Era-defining journey comes to an e...

MarketBeat

Aug 18th, 2026

Pzena Investment Management LLC buys shares of 1,157,273 Envista Holdings Corporation $NVST.

Pzena Investment Management LLC buys shares of 1,157,273 Envista Holdings Corporation $NVST. August 18, 2026 Key points. * Pzena Investment Management initiated a 1.16 million-share stake in Envista, valued at approximately $30.5 million and representing about 0.71% of the company. * Analyst sentiment is moderately positive: Envista has a consensus "Moderate Buy" rating and an average price target of $29.31, with recent target increases from Piper Sandler and JPMorgan. * Envista exceeded quarterly expectations, reporting $0.41 in EPS versus $0.34 expected and $730.5 million in revenue. Sales rose 7.1% year over year, while full-year EPS guidance stands at $1.50-$1.55. * Five stocks to consider instead of Envista. Pzena Investment Management LLC bought a new stake in Envista Holdings Corporation (NYSE:NVST - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,157,273 shares of the company's stock, valued at approximately $30,494,000. Pzena Investment Management LLC owned approximately 0.71% of Envista at the end of the most recent reporting period. A number of other institutional investors have also recently made changes to their positions in NVST. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Envista in the 2nd quarter valued at $25,000. Caitong International Asset Management Co. Ltd boosted its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock worth $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its stake in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company's stock worth $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company's stock worth $44,000 after buying an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after buying an additional 949 shares in the last quarter. Analyst ratings changes. Several equities analysts have recently weighed in on NVST shares. Piper Sandler reissued a "neutral" rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. Evercore reiterated an "outperform" rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on shares of Envista from $26.00 to $29.00 and gave the stock a "neutral" rating in a research note on Thursday, May 7th. Morgan Stanley set a $23.00 target price on shares of Envista in a research note on Thursday, August 6th. Finally, Zacks Research upgraded Envista from a "hold" rating to a "strong-buy" rating in a research report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $29.31. Discover more Insider trades screener Stock ratings screener Dividend screener tool Envista price performance. NYSE:NVST opened at $27.68 on Tuesday. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The stock's fifty day moving average is $26.66 and its two-hundred day moving average is $26.19. The company has a market capitalization of $4.45 billion, a P/E ratio of 47.72, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analysts' expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company's revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year. Envista profile. Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software. Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments. Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Envista, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list. While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Envista

Vice President - Human Resources, Diagnostics

About the job